We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Safety and Survival Profile for CAR-T Therapy Trial

News   Dec 03, 2018 | Original story from The University of Texas MD Anderson Cancer Center

 
CAR-T Therapy 2-year Survival Rates for People with B-Cell Lymphoma

Histopathology of diffuse large B-cell lymphoma occurring in the tonsil.

 
 
Advertisement
 

RELATED ARTICLES

MOBILion Systems and Protein Metrics Join Forces

News

Companies integrate the Byos® software suite with high-resolution ion mobility mass spectrometry and accelerate biotherapeutic characterization workflows.

READ MORE

Preventing Chemotherapy From Damaging the Heart

News

Researchers have discovered that the chemotherapy drug doxorubicin is able to enter heart cells by hitchhiking on a specific type of protein that functions as a transporter to move drugs from the blood into heart cells. By introducing another anti-cancer drug in advance of the chemotherapy, the team was able to block the transporter protein.

READ MORE

A Promising Way To Find New Anticancer Drugs

News

Enzymes known as histone deacetylases are targets for a handful of anticancer drugs due to their ability to affect gene expression. Now, researchers have developed a new method to investigate how these enzymes work on a molecular level. This approach could help to identify new anticancer drug candidates quickly.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE